CURRENT EYE RESEARCH is a prestigious academic journal published by Taylor & Francis Inc, focusing on advancing the field of ophthalmology and its intersection with cellular and molecular neuroscience. Since its inception in 1981, this journal has provided a vital platform for original research, reviews, and technical notes, presenting a wealth of knowledge to practitioners and researchers alike. With an impressive 2023 impact factor reflected in its ranking of Q2 in Ophthalmology and Q2 in Sensory Systems, and a Q3 ranking in Cellular and Molecular Neuroscience, CURRENT EYE RESEARCH plays a crucial role in fostering interdisciplinary collaboration and innovation. The journal is indexed in Scopus, where it holds strong positions in both the Medicine and Neuroscience categories, enhancing its visibility and reach. Researchers and professionals in these fields can access cutting-edge findings and contribute to the ongoing discourse surrounding eye health, making it an essential resource for anyone invested in advancing knowledge and treatment in ophthalmic science.

Investigative Ophthalmology & Visual Science (IOVS) is a leading academic journal published by the Association for Research in Vision and Ophthalmology, dedicated to advancing the field of ophthalmology and visual science. With an impressive impact factor and ranking in the Q1 category for both Ophthalmology and Sensory Systems, IOVS is well-respected for disseminating cutting-edge research and innovative discoveries. Established in 1977, this Open Access journal allows for broad accessibility to pioneering studies, fostering collaboration among researchers, clinicians, and students. The journal has consistently maintained high visibility in the academic community, evidenced by its robust rankings in Scopus, including Rank #16 in Ophthalmology. As it continues to pave the way for future developments in the understanding and treatment of ocular diseases, IOVS serves as an invaluable resource for those immersed in the complex field of visual science.

OPHTHALMOLOGICA is a prestigious journal published by KARGER, dedicated to the dynamic field of ophthalmology and its interdisciplinary connections with medicine and sensory systems. With a rich history spanning over a century since its inception in 1899, this journal is esteemed for its high-quality research and impactful contributions, maintaining an impressive Q1 quartile ranking in both ophthalmology and miscellaneous medicine as of 2023, alongside a notable Q2 status in sensory systems. The journal's influence is reinforced by its Scopus rankings, where it ranks 26th out of 137 in ophthalmology, showcasing a strong percentile position of 81. Based in Basel, Switzerland, OPHTHALMOLOGICA serves as an essential platform for researchers, professionals, and students, providing essential insights, reviews, and studies that push the boundaries of knowledge in the vision sciences. Although it does not currently offer open access, its contributions are critical for those pursuing advancements in ocular health and related disciplines.

Ophthalmic Research, with ISSN 0030-3747 and E-ISSN 1423-0259, is a distinguished peer-reviewed journal published by Karger in Switzerland. Established in 1970, this journal serves as a vital resource for exploration and dissemination of knowledge within the fields of Ophthalmology, Cellular and Molecular Neuroscience, and Sensory Systems, maintaining its relevance through its convergence into modern research methodologies leading up to 2024. With impressive rankings in 2023, it holds a Q2 quartile in both Ophthalmology and Medicine (miscellaneous), reflecting its significant contribution to the academic community, alongside Scopus ranks that position it favorably in the competitive landscape of medical and neuroscientific literature. Although not open access, the journal ensures that high-quality research remains accessible to its readership, which includes researchers, professionals, and students eager to stay at the forefront of ophthalmic advancements. By fostering interdisciplinary collaboration and facilitating high-level discourse, Ophthalmic Research is pivotal for those committed to advancing the future of eye care and vision sciences.

Optometry and Vision Science is a premier journal published by Lippincott Williams & Wilkins, dedicated to advancing the field of optometry and ophthalmology. With a rich history dating back to 1905 and a strong emphasis on scientific rigor, the journal has established itself as a vital resource for researchers, professionals, and students alike. Currently ranked in the Q2 category for both Ophthalmology and Optometry, it occupies a significant position in the academic community, as evidenced by its Scopus rankings of #61 among 137 in Medicine - Ophthalmology and #6 among 12 in Health Professions - Optometry. The journal publishes original research, clinical studies, and critical reviews that contribute to the understanding of visual science, the development of innovative practices, and the enhancement of patient care. Although it is not open access, its impactful content is available to subscribers and institutions, fostering a deeper insight into the complexities of vision science. As we approach the journal's centennial milestone in 2024, Optometry and Vision Science continues to reflect the evolving landscape of eye care research and is poised to inspire a new generation of vision scientists.

JOURNAL FRANCAIS D OPHTALMOLOGIE, published by MASSON EDITEUR, is a prominent peer-reviewed journal that serves as a vital resource in the field of ophthalmology. Launched in 1978, this esteemed publication continues to make significant contributions to the advancement of ocular health and vision science, with its scope encompassing clinical practices, innovative research, and the latest technological advancements in ophthalmic care. Based in France, the journal is recognized in the 2023 category quartiles with a Q3 ranking in ophthalmology, reflecting its dedication to quality scholarship within a competitive landscape, as evidenced by its positioning in the 30th percentile of the Scopus rankings. While it operates without Open Access, the journal remains crucial for professionals, researchers, and students alike, providing a platform for sharing knowledge and fostering collaborations in the global ophthalmological community.

Expert Review of Ophthalmology is a leading academic journal published by ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD, specializing in the rapidly evolving field of ophthalmology. With its ISSN 1746-9899 and E-ISSN 1746-9902, this journal has been at the forefront of disseminating critical research and insightful reviews since its inception in 2006. Covering a broad spectrum of topics within ophthalmology, it plays a pivotal role in advancing knowledge and practice, especially given its prestigious standings in various quartile rankings, including Q1 in Public Health and Q2 in Immunology and Allergy for 2023. The journal aims to provide professionals, researchers, and students with comprehensive perspectives on contemporary challenges and innovations in ophthalmology. Generously supported by a robust peer-review process, the journal ensures that all published works meet high academic standards, thereby serving as a vital resource for anyone looking to stay informed about the latest developments in eye care and vision science. By bridging research and clinical application, Expert Review of Ophthalmology is essential for those aiming to contribute meaningfully to this critical field.

Canadian Journal of Ophthalmology - Journal Canadien d'Ophtalmologie, published by the prestigious Canadian Ophthalmological Society, serves as a leading platform for disseminating cutting-edge research in the field of ophthalmology. With an ISSN of 0008-4182 and E-ISSN 1715-3360, the journal boasts a commendable impact factor and maintains a strong presence within the medicine and ophthalmology categories, ranking in the Q2 quartile. This journal not only provides significant insights into clinical practices and advancements but also contributes to the understanding of ocular health issues facing contemporary society. Since its inception in 1966, it has published high-quality research, making substantial strides in both practical and theoretical aspects of ophthalmology until 2024. Although it is not an open-access journal, it establishes a vital resource for researchers, professionals, and students alike, fostering an informed community dedicated to improving vision care.

Augenheilkunde Up2date is a pivotal journal in the field of ophthalmology, published by GEORG THIEME VERLAG KG, a renowned publisher known for its commitment to advancing medical knowledge. With its ISSN 1616-9719 and E-ISSN 1616-9735, this journal serves as a vital resource for researchers, professionals, and students interested in the latest developments and nuanced discussions in eye health. Although not available as open access, its curated content offers significant insights into contemporary research, clinical practices, and emerging trends in ophthalmology, thus promoting the continuous professional development of its readers. There is an emphasis on providing comprehensive reviews that encapsulate the pertinent advancements in the field, making it an essential publication for those aiming to enhance their expertise in eye care and vision science.

BMC Ophthalmology is a premier open access journal dedicated to advancing the field of ophthalmology through the publication of high-quality, peer-reviewed research. Published by BMC in the United Kingdom, this journal has been a vital resource since its inception in 2001 and continuously contributes to the global dialogue in vision science. With an impact factor reflecting its growing influence, BMC Ophthalmology is ranked among the top quartiles (Q2) in both general medicine and ophthalmology, emphasizing its significance in medical research. The journal encourages submissions that explore innovative diagnostics, treatment approaches, and understandings of various ocular diseases, thereby appealing to researchers, clinicians, and students alike. As an open access platform, it ensures that cutting-edge research is not only published but also readily accessible to a worldwide audience, promoting further study and collaboration in this essential area of medicine.